Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Medchemexpress LLC Rapastinel Trifluoroacetate | 1435786-04-1 | 98.0% | 527.49 | 100 MG
Supplier: Medchemexpress LLC HY16728B100MG
Rapastinel Trifluoroacetate (GLYX-13 Trifluoroacetate) is an NMDA receptor modulator with glycine-site partial agonist properties. It has potential for treating major depressive disorder and is currently in phase II clinical development as an adjunctive therapy for this condition. Studies have shown that Rapastinel Trifluoroacetate produces an antidepressant-like effect and an anxiolytic effect in animal models, without altering locomotor activity.
- NMDA receptor modulator with glycine-site partial agonist properties
- Potential for treating major depressive disorder
- Phase II clinical development as an adjunctive therapy
- Produces antidepressant-like and anxiolytic effects in animal models
- Does not alter locomotor activity
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?